image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 7.79
0.646 %
$ 3 B
Market Cap
-51.93
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one LFST stock under the worst case scenario is HIDDEN Compared to the current market price of 7.79 USD, LifeStance Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one LFST stock under the base case scenario is HIDDEN Compared to the current market price of 7.79 USD, LifeStance Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one LFST stock under the best case scenario is HIDDEN Compared to the current market price of 7.79 USD, LifeStance Health Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
1.06 B REVENUE
22.82%
-189 M OPERATING INCOME
10.01%
-186 M NET INCOME
13.59%
-16.9 M OPERATING CASH FLOW
-31.98%
-60.3 M INVESTING CASH FLOW
56.73%
47.4 M FINANCING CASH FLOW
0.34%
313 M REVENUE
0.13%
47 K OPERATING INCOME
100.30%
-5.96 M NET INCOME
74.41%
22.7 M OPERATING CASH FLOW
-48.43%
-5.05 M INVESTING CASH FLOW
1.15%
-2.02 M FINANCING CASH FLOW
-41.41%
Balance Sheet LifeStance Health Group, Inc.
image
Current Assets 226 M
Cash & Short-Term Investments 78.8 M
Receivables 126 M
Other Current Assets 21.3 M
Non-Current Assets 2.01 B
Long-Term Investments 2.93 M
PP&E 359 M
Other Non-Current Assets 1.65 B
Current Liabilities 203 M
Accounts Payable 7.05 M
Short-Term Debt 49.4 M
Other Current Liabilities 146 M
Non-Current Liabilities 601 M
Long-Term Debt 462 M
Other Non-Current Liabilities 140 M
EFFICIENCY
Earnings Waterfall LifeStance Health Group, Inc.
image
Revenue 1.06 B
Cost Of Revenue 754 M
Gross Profit 302 M
Operating Expenses 491 M
Operating Income -189 M
Other Expenses -2.87 M
Net Income -186 M
RATIOS
28.62% GROSS MARGIN
28.62%
-17.92% OPERATING MARGIN
-17.92%
-17.64% NET MARGIN
-17.64%
-13.04% ROE
-13.04%
-8.34% ROA
-8.34%
-8.20% ROIC
-8.20%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis LifeStance Health Group, Inc.
image
Net Income -186 M
Depreciation & Amortization 80.4 M
Capital Expenditures -40.5 M
Stock-Based Compensation 99.4 M
Change in Working Capital -33.7 M
Others 17.1 M
Free Cash Flow -57.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets LifeStance Health Group, Inc.
image
LFST has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership LifeStance Health Group, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
644 K USD 2
6-9 MONTHS
2.05 M USD 4
9-12 MONTHS
177 M USD 14
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Nov 27, 2024
Sell 283 K USD
Bessler Robert
Director
- 37500
7.54 USD
3 months ago
Nov 27, 2024
Sell 283 K USD
Bessler Robert
Director
- 37500
7.54 USD
3 months ago
Nov 13, 2024
Sell 78.5 K USD
Miller Lisa K
See Remarks
- 10540
7.45 USD
6 months ago
Aug 23, 2024
Sell 33.1 K USD
Varanakis Ann
Chief People Officer
- 5269
6.28 USD
8 months ago
Jun 14, 2024
Sell 782 K USD
Qureshi Danish J.
See Remarks
- 150000
5.2101 USD
8 months ago
Jun 12, 2024
Sell 332 K USD
Pardo Ryan
See Remarks
- 61508
5.4 USD
8 months ago
Jun 11, 2024
Sell 471 K USD
Mullins Kevin Michael
Chief Development Officer
- 85093
5.53 USD
8 months ago
Jun 10, 2024
Sell 436 K USD
Qureshi Danish J.
See Remarks
- 83109
5.25 USD
9 months ago
May 24, 2024
Sell 22.4 M USD
Summit Partners Growth Equity Fund IX-A, L.P.
10 percent owner
- 3802345
5.89 USD
9 months ago
May 24, 2024
Sell 22.4 M USD
SUMMIT PARTNERS L P
other: Manager of GP of 10% owner
- 3802345
5.89 USD
9 months ago
May 24, 2024
Sell 9.57 M USD
CRISAN JEFFREY
director, other: Member of 10% Group
- 1624638
5.89 USD
9 months ago
May 24, 2024
Sell 9.57 M USD
Silversmith Partners I GP, LLC
other: Member of 10% Group
- 1624638
5.89 USD
9 months ago
May 24, 2024
Sell 22.4 M USD
BLACK DARREN M.
director, 10 percent owner:
- 3802345
5.89 USD
9 months ago
May 24, 2024
Sell 85.8 M USD
TPG GP A, LLC
10 percent owner
- 14573017
5.8906 USD
9 months ago
May 10, 2024
Sell 14 K USD
Cipollone Paula
See Remarks
- 2000
7 USD
9 months ago
May 13, 2024
Sell 349 K USD
Cipollone Paula
See Remarks
- 48278
7.22 USD
11 months ago
Apr 01, 2024
Sell 76.9 K USD
Qureshi Danish J.
See Remarks
- 12965
5.93 USD
11 months ago
Apr 01, 2024
Sell 58.3 K USD
Pardo Ryan
See Remarks
- 9830
5.93 USD
11 months ago
Apr 01, 2024
Sell 60 K USD
Pantaleoni Pablo
Chief Digital Officer
- 10116
5.93 USD
11 months ago
Apr 01, 2024
Sell 57.4 K USD
Mullins Kevin Michael
Chief Development Officer
- 9688
5.93 USD
1 year ago
Jan 03, 2024
Sell 25.1 K USD
Cipollone Paula
See Remarks
- 3369
7.45 USD
11 months ago
Mar 15, 2024
Sell 1.35 M USD
Burdick Kenneth A
Chief Executive Officer
- 214605
6.28 USD
11 months ago
Mar 14, 2024
Sell 282 K USD
Mullins Kevin Michael
Chief Development Officer
- 44540
6.33 USD
11 months ago
Mar 14, 2024
Sell 249 K USD
Pardo Ryan
See Remarks
- 39384
6.33 USD
11 months ago
Mar 13, 2024
Sell 973 K USD
Qureshi Danish J.
See Remarks
- 153943
6.32 USD
11 months ago
Mar 12, 2024
Sell 293 K USD
Pantaleoni Pablo
Chief Digital Officer
- 43304
6.76 USD
11 months ago
Mar 11, 2024
Sell 97 K USD
Cipollone Paula
See Remarks
- 13996
6.93 USD
11 months ago
Mar 11, 2024
Sell 107 K USD
Varanakis Ann
Chief People Officer
- 15434
6.93 USD
11 months ago
Mar 11, 2024
Sell 408 K USD
Bourdon David
Chief Financial Officer
- 58826
6.93 USD
1 year ago
Mar 01, 2024
Sell 923 K USD
Mullins Kevin Michael
Chief Development Officer
- 115136
8.02 USD
1 year ago
Dec 01, 2023
Sell 741 K USD
Mullins Kevin Michael
Chief Development Officer
- 113334
6.54 USD
1 year ago
Nov 06, 2023
Sell 1.84 K USD
Mullins Kevin Michael
Chief Development Officer
- 300
6.12 USD
1 year ago
Nov 07, 2023
Sell 196 K USD
Mullins Kevin Michael
Chief Development Officer
- 32056
6.12 USD
1 year ago
Nov 03, 2023
Sell 496 K USD
Mullins Kevin Michael
Chief Development Officer
- 80977
6.13 USD
1 year ago
Oct 02, 2023
Sell 749 K USD
Mullins Kevin Michael
Chief Development Officer
- 113333
6.61 USD
1 year ago
Aug 31, 2023
Sell 98.7 K USD
Gouk Warren
Chief Administrative Officer
- 11966
8.25 USD
1 year ago
Sep 01, 2023
Sell 314 K USD
Gouk Warren
Chief Administrative Officer
- 38058
8.25 USD
1 year ago
Aug 24, 2023
Sell 43 K USD
Varanakis Ann
Chief People Officer
- 5661
7.6 USD
1 year ago
Jul 06, 2023
Sell 1.17 M USD
Mullins Kevin Michael
Chief Development Officer
- 135400
8.67 USD
1 year ago
Jul 03, 2023
Sell 491 K USD
Mullins Kevin Michael
Chief Development Officer
- 54600
9 USD
1 year ago
Jul 05, 2023
Sell 1.31 M USD
Mullins Kevin Michael
Chief Development Officer
- 150000
8.72 USD
1 year ago
Jun 28, 2023
Sell 24 K USD
Patel-Dunn Anisha
Chief Medical Officer
- 2602
9.24 USD
1 year ago
Jun 23, 2023
Sell 594 K USD
Mullins Kevin Michael
Chief Development Officer
- 65832
9.02 USD
1 year ago
Jun 26, 2023
Sell 447 K USD
Pardo Ryan
See Remarks
- 50136
8.91 USD
1 year ago
Jun 22, 2023
Sell 523 K USD
Gouk Warren
Chief Administrative Officer
- 57754
9.05 USD
1 year ago
Jun 21, 2023
Sell 648 K USD
Qureshi Danish J.
See Remarks
- 71811
9.03 USD
1 year ago
Jun 21, 2023
Sell 5.32 K USD
Qureshi Danish J.
See Remarks
- 587
9.07 USD
1 year ago
Jun 14, 2023
Sell 412 K USD
Gouk Warren
Chief Administrative Officer
- 45984
8.95 USD
1 year ago
Jun 13, 2023
Sell 411 K USD
Gouk Warren
Chief Administrative Officer
- 47142
8.71 USD
1 year ago
Jun 12, 2023
Sell 24.3 K USD
Gouk Warren
Chief Administrative Officer
- 2858
8.51 USD
1 year ago
Apr 04, 2023
Sell 531 K USD
Mullins Kevin Michael
Chief Development Officer
- 69734
7.61 USD
1 year ago
Apr 04, 2023
Sell 36.5 K USD
Gouk Warren
Chief Administrative Officer
- 4785
7.62 USD
1 year ago
Apr 04, 2023
Sell 49 K USD
Pantaleoni Pablo
Chief Medical Officer
- 6435
7.62 USD
1 year ago
Apr 04, 2023
Sell 48.8 K USD
Mullins Kevin Michael
Chief Development Officer
- 6399
7.62 USD
1 year ago
Apr 04, 2023
Sell 66.9 K USD
Qureshi Danish J.
See Remarks
- 8775
7.62 USD
1 year ago
Apr 04, 2023
Sell 48.8 K USD
Pardo Ryan
See Remarks
- 6398
7.62 USD
1 year ago
Apr 04, 2023
Sell 55.8 K USD
Patel-Dunn Anisha
Chief Medical Officer
- 7319
7.62 USD
1 year ago
Apr 03, 2023
Sell 723 K USD
Mullins Kevin Michael
Chief Development Officer
- 97266
7.43 USD
1 year ago
Mar 15, 2023
Sell 1.22 K USD
Mullins Kevin Michael
Chief Development Officer
- 200
6.11 USD
1 year ago
Mar 16, 2023
Sell 268 K USD
Mullins Kevin Michael
Chief Development Officer
- 43705
6.14 USD
1 year ago
Mar 14, 2023
Sell 4.89 K USD
Mullins Kevin Michael
Chief Development Officer
- 800
6.11 USD
1 year ago
Mar 08, 2023
Sell 748 K USD
Mullins Kevin Michael
Chief Development Officer
- 122295
6.12 USD
2 years ago
Nov 07, 2022
Sell 109 K USD
Gouk Warren
Chief Administrative Officer
- 15106
7.2 USD
2 years ago
Oct 31, 2022
Sell 113 K USD
Gouk Warren
Chief Administrative Officer
- 15106
7.49 USD
2 years ago
Oct 24, 2022
Sell 107 K USD
Gouk Warren
Chief Administrative Officer
- 15106
7.06 USD
2 years ago
Oct 17, 2022
Sell 121 K USD
Gouk Warren
Chief Administrative Officer
- 15106
8.01 USD
2 years ago
Oct 10, 2022
Sell 113 K USD
Gouk Warren
Chief Administrative Officer
- 15106
7.45 USD
2 years ago
Oct 03, 2022
Sell 106 K USD
Gouk Warren
Chief Administrative Officer
- 15106
7.02 USD
2 years ago
Sep 30, 2022
Sell 580 K USD
Mullins Kevin Michael
Chief Development Officer
- 82520
7.03 USD
2 years ago
Sep 08, 2022
Sell 466 K USD
Gouk Warren
Chief Administrative Officer
- 51672
9.01 USD
2 years ago
Sep 06, 2022
Sell 241 K USD
Gouk Warren
Chief Administrative Officer
- 34449
7 USD
2 years ago
Aug 23, 2022
Sell 121 K USD
Gouk Warren
Chief Administrative Officer
- 17226
7.02 USD
2 years ago
Aug 15, 2022
Sell 135 K USD
Gouk Warren
Chief Administrative Officer
- 17226
7.85 USD
2 years ago
Aug 08, 2022
Sell 126 K USD
Gouk Warren
Chief Administrative Officer
- 17226
7.3 USD
2 years ago
Aug 03, 2022
Sell 482 K USD
Gouk Warren
Chief Administrative Officer
- 68904
7 USD
2 years ago
Jun 09, 2022
Sell 73.2 K USD
Gouk Warren
Chief Administrative Officer
- 10000
7.32 USD
2 years ago
Jun 09, 2022
Sell 36.6 K USD
Gouk Warren
Chief Administrative Officer
- 5000
7.32 USD
2 years ago
Jun 13, 2022
Sell 18.5 K USD
Patel-Dunn Anisha
Chief Medical Officer
- 3463
5.34 USD
2 years ago
Jun 13, 2022
Sell 302 K USD
Pardo Ryan
See Remarks
- 56370
5.35 USD
2 years ago
Jun 13, 2022
Sell 457 K USD
Qureshi Danish J.
Chief Growth Officer
- 85879
5.32 USD
2 years ago
Jun 13, 2022
Sell 418 K USD
Mullins Kevin Michael
Chief Development Officer
- 78858
5.3 USD
2 years ago
Jun 13, 2022
Sell 468 K USD
Booth Gwen H.
Chief Operating Officer
- 88798
5.27 USD
2 years ago
Jun 13, 2022
Sell 14.1 K USD
Gorcyca Felicia
Chief People Officer
- 2638
5.33 USD
2 years ago
Jun 13, 2022
Sell 1.75 M USD
Lester Michael K.
President and CEO
- 328615
5.33 USD
2 years ago
Jun 09, 2022
Sell 73.2 K USD
Gouk Warren
Chief Administrative Officer
- 10000
7.32 USD
2 years ago
Apr 20, 2022
Sell 494 K USD
Mullins Kevin Michael
Chief Development Officer
- 46283
10.68 USD
2 years ago
Mar 14, 2022
Sell 146 K USD
Bruff Jesse Michael
Chief Financial Officer
- 18401
7.92 USD
2 years ago
Mar 15, 2022
Sell 762 USD
Bruff Jesse Michael
Chief Financial Officer
- 86
8.86 USD
3 years ago
Jun 25, 2021
Sell 19.4 M USD
Summit Partners Growth Equity Fund IX-A, L.P.
Director
- 1140704
17.01 USD
3 years ago
Jun 25, 2021
Sell 19.4 M USD
SUMMIT PARTNERS L P
- 1140704
17.01 USD
3 years ago
Jun 25, 2021
Sell 8.29 M USD
CRISAN JEFFREY
Director
- 487391
17.01 USD
3 years ago
Jun 25, 2021
Sell 8.29 M USD
Silversmith Partners I GP, LLC
- 487391
17.01 USD
3 years ago
Jun 25, 2021
Sell 19.4 M USD
BLACK DARREN M.
Director
- 1140704
17.01 USD
3 years ago
Jun 25, 2021
Sell 74.4 M USD
TPG Group Holdings (SBS) Advisors, Inc.
10 percent owner
- 4371905
17.01 USD
3 years ago
Jun 14, 2021
Sell 23.3 M USD
BLACK DARREN M.
director, 10 percent owner:
- 1368844
17.01 USD
3 years ago
Jun 14, 2021
Sell 89.2 M USD
TPG Group Holdings (SBS) Advisors, Inc.
10 percent owner
- 5246286
17.01 USD
3 years ago
Jun 14, 2021
Sell 23.3 M USD
SUMMIT PARTNERS L P
- 1368844
17.01 USD
3 years ago
Jun 14, 2021
Sell 23.3 M USD
Summit Partners Growth Equity Fund IX-A, L.P.
10 percent owner
- 1368844
17.01 USD
3 years ago
Jun 14, 2021
Sell 9.95 M USD
CRISAN JEFFREY
Director
- 584870
17.01 USD
3 years ago
Jun 14, 2021
Sell 9.95 M USD
Silversmith Partners I GP, LLC
10 percent owner
- 584870
17.01 USD
7. News
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 week ago
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025 SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. globenewswire.com - 3 weeks ago
Best Momentum Stocks to Buy for January 29th EAT, LFST and MC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 29, 2024. zacks.com - 1 month ago
New Strong Buy Stocks for January 29th MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024. zacks.com - 1 month ago
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 1 month ago
Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Tenet, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. https://thefly.com - 2 months ago
LifeStance upgraded to Buy from Neutral at Goldman Sachs Goldman Sachs upgraded LifeStance to Buy from Neutral with a $10 price target. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. The analyst believes LifeStance's continued operational execution will continue in 2025, and on an organic basis, Goldman's analysis suggests its EBITDA can grow 27% through 2027. https://thefly.com - 2 months ago
Universal Health downgraded to Neutral from Buy at Goldman Sachs Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Universal Health, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. https://thefly.com - 2 months ago
Lifeist Announces Reorganization of the Board of Directors TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced a reorganization of its Board of Directors. As part of Lifeist's ongoing efforts to enhance corporate governance and further strengthen its leadership structure, Meni Morim, a director of the Company and the former CEO of the Company, has been appointed Chairman of the Board, while Branden Spikes, a director of the Company, has transitioned to the role of Lead Independent Director. globenewswire.com - 2 months ago
Lifeist Announces the “Mikra Wellness Giveaway” Holiday Campaign TORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") and a leader in science-driven health and wellness innovations, is launching a marketing initiative for the holiday season: The Mikra Wellness Giveaway. Mikra's latest campaign, designed to reward loyal customers and drive new customer acquisition, will run from today, December 9, 2024, to January 15, 2025, and include those purchases of Mikra's scientifically formulated supplements made on wearemikra.com. globenewswire.com - 2 months ago
Lifeist Appoints Andrea Judge as Chief Executive Officer and Joins the Board of Directors TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce the appointment of Andrea Judge as Chief Executive Officer of Lifeist Wellness Inc. effective today. Andrea, the current CEO of Lifeist's subsidiary Mikra Cellular Sciences Inc. (“Mikra”) since July 2024, will now lead Lifeist in its entirety. globenewswire.com - 3 months ago
Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout globenewswire.com - 3 months ago
8. Profile Summary

LifeStance Health Group, Inc. LFST

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 3 B
Dividend Yield 0.00%
Description LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Contact 4800 N. Scottsdale Road, Scottsdale, AZ, 85251 https://www.lifestance.com
IPO Date June 10, 2021
Employees 7269
Officers Mr. Richard Hall Executive Vice President of Shared Services Ms. Lisa Keise Miller Executive Vice President of Practice Operations Ms. Ann Varanakis Chief People Officer Brooke Matthews Director of Public Relations Dr. Ujjwal Ramtekkar CPE, M.B.A., M.D. Chief Medical Officer Ms. Monica Prokocki Vice President of Investor Relations Mr. Kenneth Alan Burdick Chief Executive Officer & Chairman Mr. Ryan Pardo J.D. Chief Legal Officer & Secretary Mr. Pablo Pantaleoni Chief Digital Officer Mr. David Patrick Bourdon Chief Financial Officer & Treasurer